1. Michał Combik
Information acquired: 2025
Michał Combik is an academic who published a paper in 2017-05-16 entitled SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains. The paper was published in a journal entitled Oncotarget.